Yi Dai

4.7k total citations
172 papers, 3.9k citations indexed

About

Yi Dai is a scholar working on Molecular Biology, Plant Science and Complementary and alternative medicine. According to data from OpenAlex, Yi Dai has authored 172 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Molecular Biology, 58 papers in Plant Science and 42 papers in Complementary and alternative medicine. Recurrent topics in Yi Dai's work include Natural product bioactivities and synthesis (61 papers), Phytochemistry and Biological Activities (40 papers) and Traditional Chinese Medicine Analysis (29 papers). Yi Dai is often cited by papers focused on Natural product bioactivities and synthesis (61 papers), Phytochemistry and Biological Activities (40 papers) and Traditional Chinese Medicine Analysis (29 papers). Yi Dai collaborates with scholars based in China, Macao and Hong Kong. Yi Dai's co-authors include Xin‐Sheng Yao, Zhihong Yao, Xin‐Sheng Yao, Zifei Qin, Yang Yu, Wen‐Cai Ye, Ling Qin, Hao Gao, Yinghui Duan and Haifeng Chen and has published in prestigious journals such as Nature Communications, PLoS ONE and Biomaterials.

In The Last Decade

Yi Dai

167 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Dai China 36 2.3k 1.0k 664 624 522 172 3.9k
Qiaoyan Zhang China 41 2.3k 1.0× 1.2k 1.2× 701 1.1× 758 1.2× 661 1.3× 160 4.4k
Chunjie Wu China 33 1.7k 0.7× 703 0.7× 562 0.8× 709 1.1× 396 0.8× 142 4.2k
Jin Sook Kim South Korea 42 2.1k 0.9× 868 0.9× 490 0.7× 494 0.8× 548 1.0× 232 5.5k
Weisheng Feng China 31 2.0k 0.9× 955 0.9× 462 0.7× 463 0.7× 384 0.7× 336 4.0k
Chaomei Fu China 42 1.8k 0.8× 758 0.8× 784 1.2× 915 1.5× 486 0.9× 129 4.4k
Wei Song China 34 2.1k 0.9× 480 0.5× 440 0.7× 850 1.4× 356 0.7× 136 4.0k
Chang‐Seob Seo South Korea 33 1.9k 0.8× 763 0.8× 753 1.1× 981 1.6× 623 1.2× 326 4.4k
Xiao‐Bin Jia China 44 2.9k 1.2× 693 0.7× 765 1.2× 1.5k 2.3× 615 1.2× 259 5.2k
Lina Xu China 48 3.3k 1.5× 597 0.6× 399 0.6× 845 1.4× 361 0.7× 162 6.2k
Gon Sup Kim South Korea 38 2.2k 1.0× 1.0k 1.0× 393 0.6× 453 0.7× 569 1.1× 206 4.5k

Countries citing papers authored by Yi Dai

Since Specialization
Citations

This map shows the geographic impact of Yi Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Dai more than expected).

Fields of papers citing papers by Yi Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Dai. The network helps show where Yi Dai may publish in the future.

Co-authorship network of co-authors of Yi Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Dai. A scholar is included among the top collaborators of Yi Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Dai. Yi Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Yi, Wenhui Fang, Dongxiang Luo, et al.. (2025). Research progress in nanocrystal light-emitting diodes based on the self-assembly technology. Synthetic Metals. 312. 117868–117868.
2.
Liu, Danping, Yi Dai, Zhenzhen Zhu, et al.. (2025). Oral nanomedicine for cure of T2DM through whole-process regulation of glucose uptake/metabolism and mitochondrial repair in hepatocytes. Chemical Engineering Journal. 520. 166218–166218. 1 indexed citations
3.
Dai, Yi, et al.. (2025). Path Dependence: The “Curse” of Natural Resources on Urban Entrepreneurship. Review of Development Economics.
4.
Zeng, Dongping, Bing Wang, Zheng Xiao, et al.. (2024). Early Diagnosis and Treatment of Kidney Injury: A Focus on Urine Protein. International Journal of Molecular Sciences. 25(20). 11171–11171. 5 indexed citations
5.
Li, Shijiao, Zheng Zeng, Xu Tang, et al.. (2024). Scalable fabrication of graphene-basalt composite fabric via Layer-by-Layer deposition for efficient treatment of Cr(VI) − contaminated water. Separation and Purification Technology. 361. 131017–131017. 3 indexed citations
6.
Dai, Yi, Yang Zhang, Yupei Zhang, & Jiamiao Wang. (2024). A self-assembling conjugate of SN38 with aminoguanidine for simultaneously suppressing proliferation and migration of breast cancer cells. New Journal of Chemistry. 48(35). 15590–15598. 1 indexed citations
7.
Zhu, Haodong, Liangliang He, Jiali Chen, et al.. (2023). A compounds annotation strategy using targeted molecular networking for offline two-dimensional liquid chromatography-mass spectrometry analysis: Yupingfeng as a case study. Journal of Chromatography A. 1702. 464045–464045. 11 indexed citations
10.
Fan, Cailian, Xiyang Tang, Guonian Zhu, et al.. (2019). Qi-Li-Qiang-Xin Alleviates Isoproterenol-Induced Myocardial Injury by Inhibiting Excessive Autophagy via Activating AKT/mTOR Pathway. Frontiers in Pharmacology. 10. 1329–1329. 41 indexed citations
11.
Liu, Li‐Yin, Zhihong Yao, Zifei Qin, et al.. (2018). Mucosal immunomodulatory evaluation and chemical profile elucidation of a classical traditional Chinese formula, Bu-Zhong-Yi-Qi-Tang. Journal of Ethnopharmacology. 228. 188–199. 21 indexed citations
12.
Tian, Wenjing, Junjie Chen, Xiaojun Yao, et al.. (2017). Norsampsone E, an unprecedented decarbonyl polycyclic polyprenylated acylphloroglucinol with a homoadamantyl core from Hypericum sampsonii. RSC Advances. 7(53). 33113–33119. 8 indexed citations
13.
Qin, Ziyi, Peiqi Wang, Xinyi Li, et al.. (2016). Systematic network-based discovery of a Fam20C inhibitor (FL-1607) with apoptosis modulation in triple-negative breast cancer. Molecular BioSystems. 12(7). 2108–2118. 16 indexed citations
15.
Tian, Wenjing, Xiaojie Jin, Haifeng Chen, et al.. (2014). Novel polycyclic polyprenylated acylphloroglucinols from Hypericum sampsonii. Tetrahedron. 70(43). 7912–7916. 31 indexed citations
16.
Li, Chang, Zhihong Yao, Zifei Qin, et al.. (2014). Isolation and identification of phase I metabolites of phillyrin in rats. Fitoterapia. 97. 92–97. 25 indexed citations
17.
Wang, Guanghui, Fuquan Jiang, Yinghui Duan, et al.. (2012). Targeting Truncated Retinoid X Receptor-α by CF31 Induces TNF-α–Dependent Apoptosis. Cancer Research. 73(1). 307–318. 34 indexed citations
18.
Duan, Yinghui, Chang Li, Yi Dai, & Xin‐Sheng Yao. (2012). A New Phenylpropanediol from Sarcandra glabra (Chloranthaceae). 34(2). 208–208. 3 indexed citations
19.
Yao, Zhihong, Mingyan Liu, Yi Dai, et al.. (2011). Metabolism of Epimedium-derived Flavonoid Glycosides in Intestinal Flora of Rabbits and Its Inhibition by Gluconolactone. Chinese Journal of Natural Medicines. 9(6). 461–465. 13 indexed citations
20.
He, Rong‐Rong, et al.. (2009). The Anti-stress Effects of Sarcandra glabra Extract on Restraint-Evoked Immunocompromise. Biological and Pharmaceutical Bulletin. 32(2). 247–252. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026